| 28.07.2023 07:00 | AZN | Half-year Report | RNS |
| 27.07.2023 21:08 | AZN | IN BRIEF: Astra drug approved while another shows promise | Alliance |
| 25.07.2023 12:07 | AZN | IN BRIEF: OTAQ names interim finance chief with incumbent to move on | Alliance |
| 18.07.2023 06:04 | SHEL, AZN, NWG | Rishi Sunak to meet bosses at inaugural Business Council gathering | Alliance |
| 17.07.2023 19:33 | AZN | US FDA approves AstraZeneca and Sanofi's Beyfortus for RSV in infants | Alliance |
| 17.07.2023 18:10 | AZN | Beyfortus approved in US for infant RSV prevention | RNS |
| 14.07.2023 09:13 | SFOR, BHP, HOC | LONDON BROKER RATINGS: HSBC says 'buy' AstraZeneca but 'reduce' GSK | Alliance |
| 12.07.2023 12:08 | AZN | Astra, Daiichi get China approval for Enhertu breast cancer treatment | Alliance |
| 12.07.2023 09:27 | ENQ, FORT, HIK | LONDON BROKER RATINGS: UBS raises AstraZeneca; RBC cuts Bunzl | Alliance |
| 05.07.2023 09:34 | WISE, NRR, WINE | LONDON BROKER RATINGS: UBS likes Pearson; Liberum cuts Naked Wine | Alliance |
| 04.07.2023 09:27 | PFC, FSG, VTY | LONDON BROKER RATINGS: Dunelm, AstraZeneca and Persimmon cut | Alliance |
| 03.07.2023 15:00 | AZN | Total Voting Rights | RNS |
| 03.07.2023 08:42 | AZN | TOP NEWS: AstraZeneca, Daiichi hail datopotamab lung cancer trial | Alliance |
| 03.07.2023 07:00 | AZN | Dato-DXd significantly improved PFS in lung cancer | RNS |
| 28.06.2023 11:54 | AZN | IN BRIEF: AstraZeneca invests USD400 million in reforestation | Alliance |
| 27.06.2023 08:19 | AZN | AstraZeneca's diabetes combination treatment approved in China | Alliance |
| 26.06.2023 08:39 | AZN | EU committee recommends expanded approval for AstraZeneca's Soliris | Alliance |
| 19.06.2023 07:00 | AZN | PRESS: AstraZeneca drafts plan to spin-off in China - FT | Alliance |
| 13.06.2023 08:41 | AZN | AstraZeneca wins approval in China for Soliris in myasthenia gravis | Alliance |
| 12.06.2023 08:39 | AZN | AstraZeneca breast cancer drug capivasertib gets priority review in US | Alliance |
| 09.06.2023 09:11 | SYNC, AZN | TOP NEWS: AstraZeneca hails deal with Quell; positive danicopan data | Alliance |
| 09.06.2023 07:05 | AZN | nirsevimab recommended for infant RSV protection | RNS |
| 09.06.2023 07:00 | AZN | AstraZeneca agreement with Quell Therapeutics | RNS |
| 09.06.2023 06:53 | GSK, AZN | AstraZeneca hails RSV drug nirsevimab recommendation by FDA committee | Alliance |
| 05.06.2023 16:59 | AZN | AstraZeneca and Daiichi Sankyo report progress in cancer drug trials | Alliance |
| 05.06.2023 09:48 | AZN | AstraZeneca stops Andexxa trial early, Tagrisso reduces death risk | Alliance |
| 02.06.2023 18:04 | AZN | AstraZeneca sees positive results for Imfinzi in gastric cancers | Alliance |
| 02.06.2023 17:00 | AZN | Imfinzi improved pCR in gastric and GEJ cancers | RNS |
| 01.06.2023 15:05 | AZN | Block listing Interim Review | RNS |
| 01.06.2023 15:00 | AZN | Total Voting Rights | RNS |
| 01.06.2023 08:07 | AZN | TOP NEWS: AstraZeneca discontinues brazikumab; Lynparza wins approval | Alliance |
| 01.06.2023 07:00 | AZN | Lynparza approved in US for BRCAm prostate cancer | RNS |
| 26.05.2023 14:34 | AZN | TOP NEWS: AstraZeneca's Ultomiris wins another approval in Japan | Alliance |
| 26.05.2023 08:14 | AZN | AstraZeneca's Imfinzi plus Lynparza effective for endometrial cancer | Alliance |
| 26.05.2023 07:00 | AZN | Imfinzi + Lynparza prolonged PFS in endometrial ca | RNS |
| 22.05.2023 08:42 | DGE, JMAT, LSEG | IN BRIEF: AstraZeneca hires LSEG CFO Anna Manz as non-exec director | Alliance |
| 22.05.2023 07:05 | AZN | Directorate Change | RNS |
| 17.05.2023 09:53 | AZN | AstraZeneca's Tagrisso plus chemotherapy effective against lung cancer | Alliance |
| 17.05.2023 07:00 | AZN | Tagrisso plus chemo improved PFS in lung cancer | RNS |
| 10.05.2023 08:50 | AZN | AstraZeneca's Ultomiris approved in EU for autoimmune disease NMOSD | Alliance |
| 09.05.2023 11:00 | AZN | Director/PDMR Shareholding | RNS |
| 09.05.2023 09:29 | SHEL, AZN, HLN | LONDON BROKER RATINGS: RBC raises Intertek; Davy likes Greencoat UK | Alliance |
| 09.05.2023 09:09 | AZN | TOP NEWS: AstraZeneca's Farxiga approved in US to treat heart failure | Alliance |
| 09.05.2023 07:00 | AZN | Farxiga extended in the US for heart failure | RNS |
| 02.05.2023 15:00 | AZN | Total Voting Rights | RNS |
| 02.05.2023 14:28 | AZN | IN BRIEF: AstraZeneca Chair Michel Demare buys GBP230,000 in shares | Alliance |
| 02.05.2023 10:00 | AZN | Director/PDMR Shareholding | RNS |
| 02.05.2023 09:06 | AZN | AstraZeneca bemoans ODAC judgement on use of Lynparza drug for cancer | Alliance |
| 02.05.2023 07:00 | AZN | ODAC vote on Lynparza combo in prostate cancer | RNS |
| 01.05.2023 12:35 | AZN | AstraZeneca "disappointed" with US ODAC's guidance on Lynparza | Alliance |
| 27.04.2023 17:30 | AZN | Result of AGM | RNS |
| 27.04.2023 09:26 | AZN | TOP NEWS: AstraZeneca profit jumps despite Covid-19 sales decline | Alliance |
| 27.04.2023 07:05 | AZN | Board Committee Changes | RNS |
| 27.04.2023 07:00 | AZN | 1st Quarter Results | RNS |
| 26.04.2023 16:45 | AZN | Director Declaration | RNS |
| 20.04.2023 15:41 | WPP, ULVR, SNG | UK earnings, trading statements calendar - next 7 days | Alliance |
| 20.04.2023 15:39 | WEIR, SNX, SRP | UK shareholder meetings calendar - next 7 days | Alliance |
| 17.04.2023 06:45 | AZN | AstraZeneca reports positive results for lung cancer drug combination | Alliance |
| 14.04.2023 08:24 | AZN | TOP NEWS: AstraZeneca Covid antibody neutralises variants of concern | Alliance |
| 11.04.2023 09:28 | BOWL, ENOG, HBR | LONDON BROKER RATINGS: Redburn likes Shell; Barclays raises Persimmon | Alliance |
| 11.04.2023 08:57 | AZN | TOP NEWS: Sanofi wins US drug control from AstraZeneca in Sobi deal | Alliance |
| 11.04.2023 07:00 | AZN | Update to arrangements with Sobi and Sanofi | RNS |
| 06.04.2023 07:55 | AZN | TOP NEWS: AstraZeneca's cancer drug Lynparza approved by NHS England | Alliance |
| 05.04.2023 09:13 | AZN | AstraZeneca receives positive interim trial results for Imfinzi drug | Alliance |
| 05.04.2023 07:00 | AZN | Lynparza + Imfinzi met endpoint in ovarian cancer | RNS |
| 03.04.2023 15:00 | AZN | Total Voting Rights | RNS |
| 03.04.2023 08:45 | AZN | TOP NEWS: AstraZeneca's ultomiris recommended for EU approval | Alliance |
| 03.04.2023 07:00 | AZN | Ultomiris recommended for NMOSD EU approval | RNS |
| 30.03.2023 09:27 | AZN | AstraZeneca signs exclusive global license deal with KYM Biosciences | Alliance |
| 30.03.2023 07:00 | AZN | AstraZeneca completes KYM agreement for CMG901 | RNS |
| 27.03.2023 11:00 | AZN | Director/PDMR Shareholding | RNS |
| 27.03.2023 08:52 | AZN | TOP NEWS: AstraZeneca hails eplontersen; Enhertu wins another approval | Alliance |
| 23.03.2023 08:58 | AZN | TOP NEWS: AstraZeneca's Calquence receives first approval in China | Alliance |
| 22.03.2023 11:00 | AZN | Notice of AGM | RNS |
| 20.03.2023 15:50 | SHEL, MTVW, AZN | UK dividends calendar - next 7 days | Alliance |
